Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
100.00    -0.40 (-0.40%)
Bid:
100.00
Ask:
100.40
Spread: 0.40 (0.40%)
Market Cap: £420.35m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

10 Dec 2014 07:00

RNS Number : 2812Z
PZ CUSSONS PLC
10 December 2014
 

10 December 2014

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2014.

 

First half trading

 

Operating profits in Europe and Asia were higher than the comparative period last year, however they were lower in Africa as a result of challenging trading conditions and the devaluation of the Naira towards the end of the period. Taken together Group operating profits were 4% below that of the comparative period.

 

Excluding the impact of exchange rates, operating profits were flat period on period, comprising good organic growth in the underlying business together with the positive impact of the Five:AM acquisition offsetting the reduction in profits from Poland as a result of last year's Home Care brands sale.

 

The financial position of the Group remains strong with cash generation during the period in line with expectations.

 

Trading - Update

 

Europe

 

In the UK, performance in the washing and bathing division has been strong despite challenging trading conditions and driven by an exciting innovation pipeline. Highlights in the period include the relaunch of the entire Imperial Leather range and the launch of a new range of body care products under the Original Source brand.

 

In the beauty division, performance has been good with growth in the US and Australia offsetting tougher trading conditions in the UK.

 

Performance in the smaller markets of Poland and Greece was in line with expectations.

 

Asia

 

In Indonesia, the babycare portfolio has been expanded in the period with the launch of new products whilst non-babycare brands such as Original Source are performing well.

 

Performance in Australia has been good across the categories of Home Care, Personal Care, Beauty and Food & Nutrition. Five:AM, the food brand acquired in August for £44.1m in cash, is performing very well. The international expansion of Rafferty's Garden, acquired last year, has commenced with the launch of the range into the New Zealand market.

 

Africa

 

In Nigeria, disruption in the north of the country has continued at a high level, resulting in a decline in sales in that region. Good growth has continued in the south of the country, in particular in the electrical goods business and in the two food and nutrition joint ventures. Whilst Nigeria has been declared Ebola free, there has been a negative impact on cross-border trade.

 

Overall operating profits in Nigeria were lower than the comparative period both as a result of tough trading conditions, particularly in the North, and of the 8% devaluation of the Naira towards the end of the period.

 

Performance in the smaller markets of Ghana and Kenya was in line with expectations.

 

Full year outlook

 

The macro environment in Nigeria in the second half, which includes the February presidential elections and potential further currency volatility, will be a key contributing factor to the overall result for the full year.

 

The Group remains focussed on a dynamic and fast brand renovation and innovation programme, an ongoing cost reduction programme and successful delivery of new areas of growth such as Rafferty's Garden, Five:AM and the PZ Wilmar joint venture.

 

These initiatives will contribute towards offsetting the continuing macro challenges, particularly in Nigeria, and the reduction in profits from Poland as a result of last year's Home Care brands sale.

 

Interim Announcement

 

Interim results for the half year to 30 November 2014 will be announced on Tuesday 27th January 2015.

 

An analysts' presentation will be given at 9:30am on that day at the offices of Investec, 2 Gresham Street, London, EC2V 7QP.

 

- ENDS -

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1236

Brandon Leigh - Chief Financial Officer

 

Instinctif Tel: 020 7457 2020

Toby Bates / Tim Linacre

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGBPPUPCGAB
Date   Source Headline
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.